Immune Design Corp. Deferred Tax Assets, Net of Valuation Allowance
Immune Design Corp. had Deferred Tax Assets, Net of Valuation Allowance of $0 as of 2018-12-31, per its 10-K filed 2019-03-13.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2019-03-13
- 2018-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
- 2017-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
- 2016-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
- 2015-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-13 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-13 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-14 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-07 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-15 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-31 |